Christoph Driessen

Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4

Zdeněk Škrott, Martin Mistrík, Klaus Kaae Andersen et al. · Nature · 2017 · 789 citations

Medicine, Cancer Biology, Oncology +5

Autophagy promotes MHC class II presentation of peptides from intracellular source proteins

Jörn Dengjel, Oliver Schoor, Rainer Fischer et al. · Proceedings of the National Academy of Sciences · 2005 · 633 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events

Shirin Arastu‐Kapur, Janet L. Anderl, Marianne Kraus et al. · Clinical Cancer Research · 2011 · 409 citations

Medicine, Pharmacology, Pharmacotherapy +15

Association of Checkpoint Inhibitor–Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non–Small Cell Lung Cancer

Fiamma Berner, David Bomze, Stefan Diem et al. · JAMA Oncology · 2019 · 393 citations · Full text

Life Sciences, Immunology, Oncology +17

Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

Michèle Cavo, Francesca Gay, Meral Beksaç et al. · The Lancet Haematology · 2020 · 384 citations · Full text

Medicine, Hematology, Oncology +17